Newly Approved GMS Courses

This course is a continuation of GMS OH 732.

The requested change consolidates this two-semester course into a single semester while retaining the same underlying course concepts described above. This revised version course offers that same in-depth analysis of major drug classes used in the treatment of neurological, cardiovascular, immune-related, infectious diseases and a number of other severe chronic disorders that have presented a therapeutic challenge. Special attention is given to the molecular, cellular, and circuit-specific actions of novel pharmacological agents. The course begins with foundational reviews of disease mechanisms, followed by emerging concepts and innovative treatment strategies. Discussions focus on comparing new approaches to current standards of care, critically analyzing their therapeutic advantages. This course will be required for PhD students in the Biomolecular Pharmacology Training Program as well and will typically be taken in the second semester of the first year of study. It is also open as an elective to PhD students in other biomedical science programs. (3cr)